Understanding B cell and antibody responses in lung transplantation
Project 3: Evolution, dynamics and durability of B cell and antibody responses in lung transplantation
This study is looking at how certain immune cells called B cells work in the lungs of people who have had a lung transplant, especially how they respond to infections like COVID-19 and the flu, to find ways to better protect these patients and improve their immune health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11075887 on NIH RePORTER |
What this research studies
This research investigates how B cells, which are crucial for immune responses, behave in the lungs of lung transplant patients. It focuses on a specific type of B cell that remains in the lung and responds to infections like COVID-19 and influenza. By studying these cells, the research aims to uncover how they are formed, what triggers their activation, and how they can help protect against infections and autoimmune responses. This could lead to better strategies for managing lung transplant patients and improving their immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research include lung transplant recipients and individuals with pulmonary diseases that may involve autoimmune components.
Not a fit: Patients who do not have lung transplants or related pulmonary conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the understanding of immune responses in lung transplant patients, potentially leading to improved treatments and outcomes.
How similar studies have performed: Other research has shown promising results in understanding immune responses in similar contexts, suggesting that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Randall, Troy D — University of Alabama at Birmingham
- Study coordinator: Randall, Troy D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.